Nova Leap Health Stock Net Income
NVLPF Stock | USD 0.18 0.00 0.00% |
Nova Leap Health fundamentals help investors to digest information that contributes to Nova Leap's financial success or failures. It also enables traders to predict the movement of Nova OTC Stock. The fundamental analysis module provides a way to measure Nova Leap's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Nova Leap otc stock.
Nova |
Nova Leap Health OTC Stock Net Income Analysis
Nova Leap's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Nova Leap Net Income | 1.76 M |
Most of Nova Leap's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Nova Leap Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition |
Based on the recorded statements, Nova Leap Health reported net income of 1.76 M. This is 99.48% lower than that of the Healthcare sector and significantly higher than that of the Medical Care Facilities industry. The net income for all United States stocks is 99.69% higher than that of the company.
Nova Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Nova Leap's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Nova Leap could also be used in its relative valuation, which is a method of valuing Nova Leap by comparing valuation metrics of similar companies.Nova Leap is currently under evaluation in net income category among its peers.
Nova Fundamentals
Return On Equity | -0.0309 | |||
Return On Asset | -0.0294 | |||
Profit Margin | (0.02) % | |||
Operating Margin | (0.04) % | |||
Current Valuation | 18.18 M | |||
Shares Outstanding | 86.21 M | |||
Shares Owned By Insiders | 36.06 % | |||
Price To Earning | 10.57 X | |||
Price To Book | 1.12 X | |||
Price To Sales | 0.79 X | |||
Revenue | 21.28 M | |||
Gross Profit | 7.21 M | |||
EBITDA | 3.74 M | |||
Net Income | 1.76 M | |||
Cash And Equivalents | 794.12 K | |||
Cash Per Share | 0.01 X | |||
Total Debt | 896.13 K | |||
Debt To Equity | 0.33 % | |||
Current Ratio | 0.87 X | |||
Book Value Per Share | 0.22 X | |||
Cash Flow From Operations | 2.18 M | |||
Beta | 0.66 | |||
Market Capitalization | 16.91 M | |||
Total Asset | 26.77 M | |||
Z Score | 10.8 | |||
Net Asset | 26.77 M |
About Nova Leap Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Nova Leap Health's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Nova Leap using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Nova Leap Health based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Nova OTC Stock
Nova Leap financial ratios help investors to determine whether Nova OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nova with respect to the benefits of owning Nova Leap security.